Elevara Medicines has appointedDr Mai-Britt Zoccaas CEO, effective 1 July 2026. She succeeds founder Emma Tinsley, who will ...

Clinical research is entering a new era: advances in methodological approaches, the growing integration of real-world ...

Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site staff said conducting studies ...

Diana F Clarke, Assistant Professor of Paediatrics at Boston University School of Medicine and Lead Investigator of the ...

Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, marking the start of a ...

Erasca has been granted Fast Track Designation by the FDA for ERAS‑0015, an oral pan‑RAS molecular glue being developed for ...

Avulux has received De Novo marketing authorisation from the FDA, establishing the first recognised device classification for ...

A July 2026 Leerink Partners report named Carterra a core enabling technology in the growing Lab‑in‑the‑Loop market. The ...

Hi, this project/product/partnership is going live next week – can you do some comms?’ ...

The introduction of oral GLP-1 medicines, alongside growing awareness of injectable treatments such as Wegovy and Mounjaro, ...

The UK approval of once-daily oral Wegovy is a significant moment for obesity treatment. For the first time, patients can ...

Reducing variation, preventing complications, supporting care ...